ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,412Medicare Part D Prescriptions Filled, Including Refills

Rank: 110 out of 917

$736K Total Retail Price of All Prescriptions

Rank: 36 out of 917

473 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 473 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,649 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 416 383 1 2
LEVOTHYROXINE SODIUM 401 368 2 3
OMEPRAZOLE 398 316 3 4
LISINOPRIL 363 303 4 1
HYDROCHLOROTHIAZIDE 212 172 5 9
ZOLPIDEM TARTRATE 207 170 6 21
HYDROCODONE-ACETAMINOPHEN 202 178 S3 7 6
METFORMIN HCL 197 177 8 8
LOVASTATIN 194 172 9 19
FUROSEMIDE 179 138 10 7
AMLODIPINE BESYLATE 176 161 11 5
CITALOPRAM HBR 167 134 12 15
DONEPEZIL HCL 143 138 13 32
ALENDRONATE SODIUM 137 134 14 23
METOPROLOL TARTRATE 135 106 15 11
ATENOLOL 134 117 16 12
TRAMADOL HCL 133 93 17 28
ATORVASTATIN CALCIUM 130 107 18 14
LOSARTAN POTASSIUM 120 113 19 13
POTASSIUM CHLORIDE 118 82 20 16
PRAVASTATIN SODIUM 114 91 21 20
SERTRALINE HCL 103 74 22 24
TAMSULOSIN HCL 101 91 23 25
ADVAIR DISKUS 100 84 24 47
LANTUS SOLOSTAR 98 83 25 63
AZITHROMYCIN 90 76 26 61
ALLOPURINOL 88 81 27 31
GABAPENTIN 86 49 28 17
PREDNISONE 84 68 29 34
WARFARIN SODIUM 84 68 29 10
CIPROFLOXACIN HCL 80 72 31 72
PEN NEEDLE 78 55 32 99
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 73 33 42
LOSARTAN-HYDROCHLOROTHIAZIDE 74 66 34 62
NEXIUM 67 61 35 60
FENTANYL 65 63 S2 36 58
NAMENDA 63 63 37 43
FLUTICASONE PROPIONATE 60 42 38 26
SPIRIVA 57 46 39 45
CELEBREX 56 31 40 124
LEVOFLOXACIN 55 43 41 138
PRAMIPEXOLE DIHYDROCHLORIDE 54 41 42 137
GLYBURIDE 53 47 R 43 71
AMITRIPTYLINE HCL 52 18 R 44 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.